FATE
FATE: Adawi Kamal discloses a sale
Adawi Kamal reported Sale in FATE THERAPEUTICS INC: 6582 units of Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
LoadingLoadingLoadingFATE
Adawi Kamal reported Sale in FATE THERAPEUTICS INC: 6582 units of Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
NEOV
Snow Susan H reported Grant or award in NeoVolta Inc.: 15553 units of Common Stock, dated 2025-11-10. The full Form 4 contains 2 transaction entries.
LCID
Winitzer Ori reported Sale in Lucid Group, Inc.: 1000 units of Class A Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
GNRC
Raabe Kyle Andrew reported Sale in GENERAC HOLDINGS INC.: 386 units of Common Stock, dated 2026-11-03. The full Form 4 contains 4 transaction entries.
FLYW
Pitigoi Cosmin reported Sale in Flywire Corp: 19468 units of Voting Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
OFIX
Fisher Patrick reported Sale in Orthofix Medical Inc.: 150 units of Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
ALT
Howarth Alex G. reported Grant or award in Altimmune, Inc.: 160000 units of Stock Options (option to buy) (derivative), dated 2026-11-02. The full Form 4 contains 1 transaction entry.
NDAQ
EKHOLM BORJE reported 1,449 shares of Common Stock, par value $0.01 per share in NASDAQ, INC. as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
STOK
Ticho Barry reported Sale in Stoke Therapeutics, Inc.: 6995 units of Common Stock, dated 2026-11-02. The full Form 4 contains 2 transaction entries.
CDNA
Cohen Fred E reported Gift in CareDx, Inc.: 25000 units of Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
LUXE
Kliger Michael reported Exercise or conversion in LuxExperience B.V.: 3200 units of Ordinary Share, dated 2026-11-02. The full Form 4 contains 6 transaction entries.
NEOV
Weeks Chandler G reported Grant or award in NeoVolta Inc.: 12413 units of Common Stock, dated 2025-11-10. The full Form 4 contains 2 transaction entries.
NEOV
Hass John A reported Grant or award in NeoVolta Inc.: 20791 units of Common Stock, dated 2025-11-10. The full Form 4 contains 2 transaction entries.
CCG
Zhang Lei reported Grant or award in Cheche Group Inc.: 250000 units of Class B Ordinary Shares, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
INTA
HALL JOHN T reported Exercise or conversion in Intapp, Inc.: 3000 units of Common Stock, dated 2026-11-02. The full Form 4 contains 7 transaction entries.
NVCR
Puri Michal Nath reported Sale in NovoCure Ltd: 660.00 units of Ordinary Shares, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
DXLG
Bauza Carmen reported 40,099 shares of Common Stock, $0.01 par value in DESTINATION XL GROUP, INC. as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
MRSH
Tomlinson Patrick reported Exercise or conversion in MARSH & MCLENNAN COMPANIES, INC.: 2500 units of Common Stock, dated 2026-11-02. The full Form 4 contains 3 transaction entries.
DXLG
Boyle Jack reported 48,019 shares of Common Stock, $0.01 par value in DESTINATION XL GROUP, INC. as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
DXLG
Ross Ivy reported 40,099 shares of Common Stock, $0.01 par value in DESTINATION XL GROUP, INC. as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
BBNX
Hopman Mark reported Sale in Beta Bionics, Inc.: 370.00 units of Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
EXOD
Gernetzke James reported Sale in Exodus Movement, Inc.: 5781 units of Class A Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
SRCE
Graham Tracy D reported 158 shares of Common Stock in 1ST SOURCE CORP as grants or awards dated 2026-11-03. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
KVUE
Godbole Seemantini reported Disposition to issuer in Kenvue Inc.: 37794.80 units of Deferred Share Units (derivative), dated 2026-11-02. The full Form 4 contains 1 transaction entry.
